Detalhe da pesquisa
1.
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Int J Mol Sci
; 21(1)2019 12 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881723
2.
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia
; 34(9): 2544, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665699
3.
LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia
; 33(6): 1501-1513, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607021
4.
In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies.
J Med Chem
; 60(4): 1523-1533, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28094938
5.
Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death.
Oncotarget
; 7(18): 26120-36, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27027430
6.
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice.
J Exp Med
; 213(9): 1705-22, 2016 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27455953
7.
Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.
Oncotarget
; 5(12): 4384-91, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962689
8.
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib.
Oncotarget
; 3(12): 1557-65, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23238683